Loading
RC
RemeGen Co., Ltd. Stock: price and insider trades · Hong Kong
Insider Decl.
53
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€7M
17 ops. · all time
Who traded when
BuySaleFang Jianmin9 sales
Lin Jian2 sales
Wang Liqiang2 sales
Wang Weidong2 sales
Wen Qingkai2 sales
Analyst consensus: bullish or bearish?
Analysts rate RemeGen Co., Ltd. Strong Buy (bullish), based on 16 analysts. Average price target: HK$117.53.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,031 of 26,280 companies
55.7
score / 100
Value29
Quality83
FCF yld-0.4%
Earn yld1.8%
EV/EBITDA37.7x
ROE109%
Gross mgn87%
Net mgn22%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$65.90
Analyst consensus
16 analystsStrong buy
HK$89.90Target HK$117.53(+78%)HK$145.88
Income statement
RevenueHK$3.2B
Gross profitHK$2.8B87% margin
EBITDAHK$1.1B34% margin
Net incomeHK$709.7M72.7% margin
Valuation
PER (trailing)5.7x
PER (forward)52.2x
P/Book3.8x
Beta0.46
Balance sheet & cash
Market capHK$39.3B
Total debtHK$2.2B
Free Cash Flow-HK$147.7M
Debt / Equity4%
Profitability & ownership
ROE109.1%
ROA39.0%
% insiders10.6%
% institutions32.2%
Last declaration on 24 April 2026
Declarations53 total
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00705
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00704
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00701
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00741
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00720
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00753
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00706
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00703
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00738
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00724
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00683
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00692
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00722
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00695
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00743
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00746
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00739
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00737
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00721
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00718
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00690
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00678
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00682
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00681
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00676
25 of 53 declarations
About RemeGen Co., Ltd.
RemeGen Co., Ltd., a healthcare company listed on the Hong Kong stock exchange with a market capitalisation of HKD 39.3 billion, has a record reduced to 17 filings, all published between April 2, 2026 and April 24, 2026, for trades from September 29, 2025 to April 1, 2026, from 5 filers. It holds only sales: no purchase, no grant.
Nine of the 17 sales carry an amount, EUR 7.4 million in total, with a median of EUR 573,797. The three largest are all by Fang Jianmin: EUR 1,968,720 on March 31, 2026, EUR 1,582,367 on November 27, 2025 and EUR 1,188,259 on September 29, 2025. Fang Jianmin signs 9 of the 17 filings, all sales.
Read moreShow less
Wen Qingkai, Wang Weidong, Lin Jian and Wang Liqiang each sign 2 filings, also all sales. No role is listed for these filers.
Filings appear a median of 1 day after the trade, computed on only 5 filings. The whole record falls within the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
